-
21
Machine learning prediction of metabolic dysfunction-associated fatty liver disease risk in American adults using body composition: explainable analysis based on SHapley Additive e...
Published 2025-06-01Subjects: “…MAFLD…”
Get full text
Article -
22
Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA
Published 2025-08-01Subjects: “…MAFLD…”
Get full text
Article -
23
Membrane-associated ring–CH–type finger 2 protects against metabolic dysfunction-associated fatty liver disease by targeting fatty acid synthase
Published 2025-06-01Subjects: “…MAFLD…”
Get full text
Article -
24
-
25
Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Stud...
Published 2024-12-01Subjects: “…mafld…”
Get full text
Article -
26
Role of the Annexin A protein family in liver diseases: insights and therapeutic opportunities
Published 2025-07-01Subjects: Get full text
Article -
27
Editorial: Nutriomic analysis of food and functional compounds for MAFLD prevention
Published 2025-08-01Subjects: Get full text
Article -
28
-
29
Multidimensional sleep impairment predicts steatotic liver disease spectrum risk
Published 2025-03-01Subjects: Get full text
Article -
30
-
31
Global burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021
Published 2025-04-01Subjects: Get full text
Article -
32
Elevated glucagon and postprandial hyperglycemia in fatty liver indicate early glucose intolerance in metabolic dysfunction associated steatotic liver disease
Published 2024-12-01Subjects: “…MAFLD…”
Get full text
Article -
33
Tryptophan Metabolites in the Progression of Liver Diseases
Published 2024-11-01Subjects: “…MAFLD…”
Get full text
Article -
34
INHIBITION OF THE PROSTAGLANDIN-DEGRADING ENZYME 15-PGDH AMELIORATES MASH-ASSOCIATED APOPTOSIS AND FIBROSIS IN MICE
Published 2025-06-01Subjects: Get full text
Article -
35
Reversed role of CD36 deficiency in high-fat diet or methionine/choline-deficient diet-induced hepatic steatosis and steatohepatitis
Published 2025-03-01Subjects: Get full text
Article -
36
Hepatic HSD17B6 is dispensable for diet-induced fatty liver disease in mice
Published 2025-03-01Subjects: “…MAFLD…”
Get full text
Article -
37
-
38
Preventing metabolic-associated fatty liver disease with fermented cordyceps preparation: an electronic medical record based study
Published 2025-05-01Subjects: “…MAFLD…”
Get full text
Article -
39
MAFLD - a new approach to fatty liver disease
Published 2025-05-01Subjects: “…MAFLD…”
Get full text
Article -
40